The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 9,201–9,300 of 31,469
Kaneko, H., Anzai, T., Horiuchi, K., Morimoto, K., Anzai, A., Nagai, T., Sugano, Y., Maekawa, Y., Itoh, H., Yoshikawa, T., et al. (2011) · Circulation Journal · doi:10.1253/circj.cj-11-0182 · Cited by 39
Alagona, C., Soro, A., Ylitalo, K., Salonen, R. M., Salonen, J. T., & Taskinen, M. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00243-5 · Cited by 39
Insulin resistance and adipose-derived hormones in young men with untreated obstructive sleep apnea
Hargens, T. A., Guill, S. G., Kaleth, A. S., Nickols‐Richardson, S. M., Miller, L. E., Zedalis, D., Gregg, J. M., Gwazdauskas, F., & Herbert, W. G. (2012) · Sleep And Breathing · doi:10.1007/s11325-012-0708-0 · Cited by 39
Krarup, N. T., Grarup, N., Banasik, K., Friedrichsen, M. H., Færch, K., Sandholt, C. H., Jørgensen, T., Poulsen, P., Witte, D. R., Vaag, A. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040376 · Cited by 36
Steene‐Johannessen, J., Kolle, E., Anderssen, S. A., & Andersen, L. B. (2009) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510802691771 · Cited by 39
Finkelstein, J. M., Heemels, M.-T., Shadan, S., & Weiss, U. K. (2014) · Nature · doi:10.1038/510047a · Cited by 41
Serum lipocalin-2 levels positively correlate with coronary artery disease and metabolic syndrome
Ni, J., Ma, X., Zhou, M., Pan, X., Tang, J., Hao, Y., Lu, Z., Gao, M., Bao, Y., & Jia, W. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-176 · Cited by 39
Foster, M. J., Chu, A., Petocz, P., & Samman, S. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.07.012 · Cited by 39
Gardener, H. E., Crisby, M., Sjoberg, C., Hudson, B. I., Goldberg, R. B., Mendez, A. J., Wright, C. B., Rundek, T., Elkind, M. S. V., & Sacco, R. L. (2012) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0065 · Cited by 40
Antidiabetic effects of the Cimicifuga racemosa extract Ze 450 in vitro and in vivo in ob/ob mice
Moser, C. D., Vickers, S. P., Brammer, R. J., Cheetham, S. C., & Drewe, J. (2014) · Phytomedicine · doi:10.1016/j.phymed.2014.06.002 · Cited by 39
Leptin and its Association with Somatic Depressive Symptoms in Patients with the Metabolic Syndrome
Chirinos, D. A., Goldberg, R. B., Gellman, M. D., Mendez, A. J., Gutt, M., McCalla, J. R., Llabre, M. M., & Schneiderman, N. (2013) · Annals of Behavioral Medicine · doi:10.1007/s12160-013-9479-5 · Cited by 39
Effect of age and glucoregulation on cognitive performance
Messier, C., Tsiakas, M., Gagnon, M., & Desrochers, A. (2010) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390903540323 · Cited by 39
Decreased serum chemerin levels in male Japanese patients with type 2 diabetes: sex dimorphism
Takahashi, M., Inomata, S., Okimura, Y., Iguchi, G., Fukuoka, H., Miyake, K., Koga, D., Akamatsu, S., Kasuga, M., & Takahashi, Y. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0201 · Cited by 39
Prato, S. D., Foley, J. E., Kothny, W., Kozlovski, P., Stümvoll, M., Paldánius, P. M., & Matthews, D. R. (2014) · Diabetic Medicine · doi:10.1111/dme.12508 · Cited by 39
Self-citationNogueira, J. D., Maraninchi, M., Lorec, A., Corroller, A. B., Nicolay, A., Gaudart, J., Portugal, H., Barone, R., Vialettes, B., & Valéro, R. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.66 · Cited by 40
Theuwissen, E., Plat, J., Kallen, C., van Greevenbroek, M. M. J., & Mensink, R. P. (2009) · Lipids · doi:10.1007/s11745-009-3367-6 · Cited by 39
Enos, R. T., Velázquez, K. T., McClellan, J. L., Cranford, T. L., Walla, M. D., & Murphy, E. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094897 · Cited by 39
Chen, B. H., Brennan, K., Goto, A., Song, Y., Aziz, N., You, N. Y., Wellons, M., Manson, J. E., White, D. L., Butch, A. W., et al. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.193086 · Cited by 39
Park, Y. M., Heden, T. D., Liu, Y., Nyhoff, L. M., Thyfault, J. P., Leidy, H. J., & Kanaley, J. A. (2014) · Journal of Nutrition · doi:10.3945/jn.114.202549 · Cited by 42
Effect of recreational physical activity on insulin levels in Mexican/Hispanic children
Macías-Cervantes, M. H., Malacara, J. M., Garay‐Sevilla, M. E., & Díaz-Cisneros, F. J. (2009) · European Journal of Pediatrics · doi:10.1007/s00431-008-0907-7 · Cited by 39
Caranti, D. A., Lazzer, S., Dâmaso, A. R., Agosti, F., Zennaro, R. G., de Mello, M. T., Tufik, S., & Sartório, A. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01826.x · Cited by 34
Masuyama, H., & Hiramatsu, Y. (2011) · Journal of Molecular Endocrinology · doi:10.1530/jme-11-0046 · Cited by 39
Metabolic syndrome in children and adolescents with phenylketonuria
Kanufre, V. D. C., Soares, R. D. L., Alves, M. R. A., de Aguiar, M. J. B., Starling, A. L. P., & Norton, R. D. C. (2014) · Jornal de Pediatria · doi:10.1016/j.jped.2014.06.006 · Cited by 39
Verhagen, S. N., Wassink, A. M. J., van der Graaf, Y., Gorter, P. M., Visseren, F. L. J., & the SMART Study Group (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-100 · Cited by 39
Takeshita, Y., Takamura, T., Kita, Y., et al. (2012) · Metabolism · doi:10.1016/j.metabol.2012.03.011 · Cited by 39
Vitamin D Deficiency, Interleukin 17, and Vascular Function in Rheumatoid Arthritis
Ranganathan, P., Khalatbari, S. H., Yalavarthi, S., Marder, W., Brook, R. D., & Kaplan, M. J. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.130012 · Cited by 39
DNA methylation, insulin resistance and second-generation antipsychotics in bipolar disorder
Burghardt, K. J., Goodrich, J. M., Dolinoy, D. C., & Ellingrod, V. L. (2015) · Epigenomics · doi:10.2217/epi.15.5 · Cited by 39
Pérez‐Martínez, P., Delgado‐Lista, J., García‐Ríos, A., Monagle, J. M., Gulseth, H. L., Ordovás, J. M., Shaw, D. I., Karlström, B., Kieć‐Wilk, B., Blaak, E. E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020555 · Cited by 39
Shadman, Z., Taleban, F. A., Saadat, N., & Hedayati, M. (2013) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-12-42 · Cited by 39
Mitchell, D. M., Leder, B., Cagliero, E., Mendoza, N., Henao, M. P., Hayden, D. L., Finkelstein, J., & Burnett-Bowie, S. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.111682 · Cited by 40
Blood Glucose Fluctuations in Type 2 Diabetes Patients Treated with Multiple Daily Injections
Li, F.-F., Fu, L., Zhang, W., Su, X., Wu, J.-D., Sun, J., Ye, L., & Ma, J. (2015) · Journal of Diabetes Research · doi:10.1155/2016/1028945 · Cited by 39
Sarriá, B., Martínez‐López, S., Mateos, R., & Bravo, L. (2016) · Food Research International · doi:10.1016/j.foodres.2015.12.032 · Cited by 39
Moriyama, K., & Takahashi, E. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.33985 · Cited by 39
Marics, B., Peitl, B., Varga, A., Pázmándi, K., Bácsi, A., Németh, J., Szilvássy, Z., Jancsó, G., & Dux, M. (2016) · Cephalalgia · doi:10.1177/0333102416654883 · Cited by 39
Circadian variation of the pancreatic islet transcriptome
Rakshit, K., Qian, J., Ernst, J., & Matveyenko, A. V. (2016) · Physiological Genomics · doi:10.1152/physiolgenomics.00019.2016 · Cited by 40
Gomes, J. M. G., Fabrini, S. P., & Alfenas, R. D. C. G. (2016) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000206 · Cited by 39
Forkert, E. C. O., Rendo‐Urteaga, T., Ferreira, M. V. N., de Moraes, A. C. F., Moreno, L. A., & Carvalho, H. B. (2016) · Nutrire · doi:10.1186/s41110-016-0017-7 · Cited by 44
Experimental model of glucocorticoid-induced insulin resistance
Martínez, B. B., Pereira, A. C. C., Muzetti, J. H., Telles, F. D. P., Mundim, F. G. L., & Teixeira, M. A. (2016) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-865020160100000001 · Cited by 40
Wu, T., Hung, C., Liu, C.-C., Wu, Y., Wang, L., & Yeh, H. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.37895 · Cited by 41
The preventive effect of sustained physical activity on incident nonalcoholic fatty liver disease
Kwak, M., Kim, D., Chung, G. E., Kim, W. K., & Kim, J. S. (2016) · Liver International · doi:10.1111/liv.13332 · Cited by 40
Rajendran, J., Srinivasan, A. R., Hanifah, M., & Maran, A. L. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.12.020 · Cited by 39
Henríquez, P., Matuszewski, B. J., Andreu, Y., et al. (2017) · IEEE Transactions on Multimedia · doi:10.1109/tmm.2017.2666545 · Cited by 39
Trigonelline and vildagliptin antidiabetic effect: improvement of insulin signalling pathway
Aldakinah, A.-A. A., Al‐Shorbagy, M. Y., Abdallah, D. M., & El-Abhar, H. S. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12713 · Cited by 39
Nappo, A., González‐Gil, E. M., Ahrens, W., Bammann, K., Michels, N., Moreno, L. A., Kourides, Y. A., Iacoviello, L., Mårild, S., Fraterman, A., et al. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.04.003 · Cited by 39
Jacobs, S., Kroeger, J., Schulze, M. B., Frank, L. K., Franke, A. A., Cheng, I. C., Monroe, K. R., Haiman, C. A., Kolonel, L. N., Wilkens, L. R., et al. (2017) · Current Developments in Nutrition · doi:10.3945/cdn.117.000620 · Cited by 40
Agostinis-Sobrinho, C., Abreu, S., Moreira, C., Lopes, L., García-Hermoso, A., Ramírez-Vélez, R., Correa-Bautista, J., Mota, J., & Santos, R. (2017) · NMCD. Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.04.008 · Cited by 33
Saucedo, R., Valencia‐Ortega, J., Gutiérrez, C., Basurto, L., Hernández, M., Puello, E., Rico, G., Vega, G., & Zárate, A. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0234-0 · Cited by 39
Hong, N., Yoon, H. G., Seo, D. H., Park, S., Kim, S. I., Sohn, J., & Rhee, Y. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.05.002 · Cited by 41
Perona, J. S., Schmidt‐RioValle, J., Rueda‐Medina, B., Correa‐Rodríguez, M., & González‐Jiménez, E. (2017) · Nutrition Research · doi:10.1016/j.nutres.2017.06.007 · Cited by 39
The brown-fat-secreted adipokine neuregulin 4 is decreased in gestational diabetes mellitus
Kralisch, S., Hoffmann, A., Kratzsch, J., Blüher, M., Stümvoll, M., Faßhauer, M., & Ebert, T. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.06.001 · Cited by 38
Ouerghi, N., Fradj, M. K. B., Bezrati, I., Feki, M., Kaabachi, N., & Bouassida, A. (2017) · Obesity Facts · doi:10.1159/000471882 · Cited by 39
Guelfi, K. J., Ong, M. J., Li, S., Wallman, K. E., Doherty, D. A., Fournier, P. A., Newnham, J. P., & Keelan, J. A. (2017) · Metabolism · doi:10.1016/j.metabol.2017.08.003 · Cited by 39
Exposure to perchlorate, nitrate and thiocyanate, and prevalence of diabetes mellitus
Liu, G., Zong, G., Dhana, K., Hu, Y., Blount, B. C., Morel-Espinosa, M., & Sun, Q. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx188 · Cited by 39
Vázquez-Bourgón, J., Pérez‐Iglesias, R., de la Foz, V. O., Pinilla, P. S., Díaz, Á., & Crespo‐Facorro, B. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4763-x · Cited by 41
Calcaterra, V., Giuseppe, R. D., Biino, G., et al. (2017) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2017-0239 · Cited by 39
Bozkurt, L., Göbl, C. S., Baumgartner-Parzer, S. M., Luger, A., Pacini, G., & Kautzky‐Willer, A. (2018) · International Journal of Endocrinology · doi:10.1155/2018/5463762 · Cited by 44
de Oliveira, D. G., Ghetti, F. D. F., Moreira, A. P. B., Hermsdorff, H. H. M., de Oliveira, J. M., & Ferreira, L. E. V. V. D. C. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1776-0 · Cited by 40
Chung, H. S., Hwang, H., Hwang, S. Y., Kim, N. H., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., Choi, K. M., & Yoo, H. J. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.07.024 · Cited by 39
García‐Monzón, C., Petrov, P., Rey, E., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.07.028 · Cited by 39
Jin, Y., Kanaya, A. M., Kandula, N. R., Rodríguez, L. A., & Talegawkar, S. A. (2018) · Journal of Nutrition · doi:10.1093/jn/nxy217 · Cited by 41
Double-blind, placebo-controlled trial of pioglitazone for bipolar depression.
Aftab, A., Kemp, D. E., Ganocy, S., Schinagle, M., Conroy, C. M., Brownrigg, B., D'Arcangelo, N., Goto, T., Woods, N., Serrano, M. B., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.090 · Cited by 41
Sleep Loss Disrupts Morning-to-Evening Differences in Human White Adipose Tissue Transcriptome
Wilms, B., Leineweber, E., Mölle, M., Chamorro, R., Pommerenke, C., Salinas, G., Sina, C., Lehnert, H., Oster, H., & Schmid, S. M. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01663 · Cited by 41
Age-differential association between serum uric acid and incident hypertension
Lee, S. W., Kim, H. C., Nam, C. M., Lee, H., Ahn, S. V., Oh, Y. A., & Suh, I. (2018) · Hypertension Research · doi:10.1038/s41440-018-0168-4 · Cited by 39
Gualerzi, A., Bellan, M., Smirne, C., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209216 · Cited by 39
Wang, J., Lee, W., Lee, I., Lin, S., Lee, W.-L., Liang, K., & Sheu, W. H. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00359 · Cited by 39
Hayashi, M. K., Morioka, T., Hatamori, M., Kakutani, Y., Yamazaki, Y., Kurajoh, M., Motoyama, K., Mori, K., Fukumoto, S., Shioi, A., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.01.009 · Cited by 41
Mozaffari, H., Namazi, N., Larijani, B. A., Surkan, P. J., & Azadbakht, L. (2019) · British Journal Of Nutrition · doi:10.1017/s0007114518003872 · Cited by 39
Papandreou, C., Bulló, M., Ruiz‐Canela, M., Dennis, C., Deik, A., Wang, D. Y., Guasch‐Ferré, M., Yu, E., Razquín, C., Corella, D., et al. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy262 · Cited by 39
Batrakoulis, A., Fatouros, I. G., Chatzinikolaou, A., Draganidis, D., Georgakouli, K., Παπανικολάου, Κ., Deli, C. K., Tsimeas, P. D., Avloniti, A. A., Syrou, N. F., et al. (2019) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2019.100386 · Cited by 39
Tang, X., Zhong, J., Zhang, H., Luo, Y., Liu, X., Peng, L., Zhang, Y., Qian, X., Jiang, B., Liu, J., et al. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0854-9 · Cited by 40
AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome
Calzada, M., López, N., Velasco, J. A. N., Mendiola, J., Hernández, A. I., Corbalán‐Biyang, S., Sanchez, M., & Torres-Cantero, A. M. (2019) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2019.1587604 · Cited by 37
Hsing, J. C., Nguyen, M. H., Yang, B., Yan, M., Han, S. S., Pung, E., Winter, S. J., Zhao, X., Gan, D., Hsing, A. W., et al. (2019) · Hepatology Communications · doi:10.1002/hep4.1392 · Cited by 39
Association of CREBRF variants with obesity and diabetes in Pacific Islanders from Guam and Saipan
Hanson, R. L., Safabakhsh, S., Curtis, J. M., Hsueh, W., Jones, L. I., Aflague, T., Sarmiento, J. D., Kumar, S., Blackburn, N. B., Curran, J. E., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4932-z · Cited by 39
Transient liver elastography in normal pregnancy – a longitudinal cohort study
Ribeiro, M. S., Hagström, H., Stal, P. I., et al. (2019) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2019.1629007 · Cited by 39
Aadland, E., Andersen, L. B., Resaland, G. K., & Kvalheim, O. M. (2019) · Metabolites · doi:10.3390/metabo9070129 · Cited by 39
Monk, J. M., Liddle, D. M., Hutchinson, A. L., Wu, W., Lepp, D., David, W. L., Robinson, L. E., & Power, K. A. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.07.007 · Cited by 43
Cirillo, F., Catellani, C., Lazzeroni, P., Sartori, C., Tridenti, G., Vezzani, C., Fulghesu, A. M., Madeddu, E., Amarri, S., & Street, M. E. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1725967 · Cited by 39
Gurian, E., Giraudi, P. J., Rosso, N., et al. (2020) · Analytica Chimica Acta · doi:10.1016/j.aca.2020.02.040 · Cited by 39
Zheng, K. I., Liu, W., Pan, X.-Y., Ma, H., Zhu, P., Wu, X., Targher, G., Byrne, C. D., Wang, X., Chen, Y., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001174 · Cited by 39
Said, E., Mousa, S., Fawzi, M., Sabry, N. A., & Farid, S. F. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2020.06.013 · Cited by 39
Subfatin and asprosin, two new metabolic players of polycystic ovary syndrome
Deniz, R., Yavuzkır, Ş., Uğur, K., Üstebay, D. Ü., Baykuş, Y., Üstebay, S., & Aydın, S. (2020) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2020.1758926 · Cited by 43
Sprung, V. S., Kemp, G. J., Wilding, J. P. H., Adams, V. L., Murphy, K., Burgess, M. I., Emegbo, S., Thomas, M., Needham, A. J., Weimken, A., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038856 · Cited by 39
Effect of Long-Term Moderate Physical Exercise on Irisin between Normal Weight and Obese Men
Rashid, F. A., Abbas, H. J., Naser, N. A., & Ali, H. A. (2020) · The Scientific World JOURNAL · doi:10.1155/2020/1897027 · Cited by 39
Pedersen, J. S., Rygg, M. O., Kristiansen, V. B., Olsen, B. H., Serizawa, R., Holst, J. J., Madsbad, S., Gluud, L. L., Bendtsen, F., & Albrechtsen, N. J. W. (2020) · Hepatology Communications · doi:10.1002/hep4.1562 · Cited by 40
Yang, L., Qiu, Y., Ling, W., Liu, Z., Wang, C., Wang, C., Peng, X., Wang, L., & Chen, J. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02379-x · Cited by 42
Adherence to a Mediterranean Diet and Thyroid Function in Obesity: A Cross-Sectional Apulian Survey
Zupo, R., Castellana, F., Panza, F., Lampignano, L., Murro, I., Noia, C. D., Triggiani, V., Giannelli, G., Sardone, R., & Pergola, G. D. (2020) · Nutrients · doi:10.3390/nu12103173 · Cited by 42
Li, J. H., Szczerbiński, Ł., Dawed, A. Y., Kaur, V., Todd, J. N., Pearson, E. R., & Florez, J. C. (2020) · Diabetes · doi:10.2337/db20-0530 · Cited by 39
Wasana, K. G. P., Attanayake, A. P., Weerarathna, T. P., & Jayatilaka, K. A. P. W. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153431 · Cited by 42
Bini, S., D’Erasmo, L., Costanzo, A. D., Minicocci, I., Pecce, V., & Arca, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020742 · Cited by 38
GLP-1 and hunger modulate incentive motivation depending on insulin sensitivity in humans
Hanßen, R., Kretschmer, A. C., Rigoux, L., Albus, K., Thanarajah, S. E., Sitnikow, T., Melzer, C., Cornely, O. A., Brüning, J. C., & Tittgemeyer, M. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101163 · Cited by 42
Changes in Ghrelin and Glucagon following a Low Glycemic Load Diet in Women with PCOS
Hoover, S. E., Gower, B. A., Cedillo, Y. E., Chandler-Laney, P. C., Deemer, S. E., & Goss, A. M. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab028 · Cited by 51
Yook, J., Thomas, S. S., Toney, A. M., You, M., Kim, Y.-C., Liu, Z., Lee, J., & Chung, S. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab222 · Cited by 41
Mohany, K. M., Rugaie, O. A., Al‐Wutayd, O., & Al‐Nafeesah, A. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00829-z · Cited by 39
Serum ferritin levels predict incident non-alcoholic fatty liver disease in healthy Korean men
Kim, C., Chang, Y., Sung, E., Shin, H. C., & Ryu, S. (2012) · Metabolism · doi:10.1016/j.metabol.2012.01.007 · Cited by 39
Prasad, M., Gatasheh, M. K., Alshuniaber, M. A., Krishnamoorthy, R., Rajagopal, P., Krishnamoorthy, K., Vijayalakshmi, P., Veeraraghavan, V. P., & Jayaraman, S. (2022) · Antioxidants · doi:10.3390/antiox11122436 · Cited by 40
Han, J., Yang, N., Zhang, F., Zhang, C., Liang, F., Xie, W., & Chen, W. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.05.016 · Cited by 39
Esmaillzadeh, A., Zakizadeh, E., Faghihimani, E., Gohari, M. R., & Jazayeri, S. (2015) · Europe PMC (PubMed Central) · Cited by 39
Assessment of serum leptin, insulin resistance and metabolic syndrome in patients with skin tags
Shaheen, M. A., Fattah, N. S. A. A., Sayed, Y. A. A., et al. (2011) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04401.x · Cited by 39
High prevalence of prediabetes in a Swedish cohort of severely obese children
Ek, A. E., Rössner, S. M., Hagman, E., & Marcus, C. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12136 · Cited by 38
Civera, M., Urios, A., García-Torres, M. L., Ortega, J., Martínez-Valls, J. F., Fernández, N. C., del Olmo, J. A., Ferrandez, A., Rodrigo, J. M., & Montoliu, C. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1070 · Cited by 39
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
